Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2021-10-01 | 2021-10-25 | 146522 |
| APO-SIMVASTATIN | 80MG | TABLET | Resolved | 2022-01-14 | 2022-04-18 | 152776 |
| APO-SIMVASTATIN | 20MG | TABLET | Resolved | 2019-04-04 | 2019-04-15 | 80545 |
| APO-SIMVASTATIN | 80MG | TABLET | Resolved | 2018-02-13 | 2018-03-20 | 39673 |
| APO-SIMVASTATIN | 5MG | TABLET | Resolved | 2018-10-11 | 2018-11-02 | 63803 |
| APO-SIMVASTATIN | 10MG | TABLET | Resolved | 2022-02-11 | 2022-03-25 | 154770 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2022-03-11 | 2022-03-25 | 156552 |
| APO-SIMVASTATIN | 20MG | TABLET | Resolved | 2022-04-01 | 2022-04-29 | 157704 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2022-09-16 | 2022-11-25 | 169516 |
| APO-SIMVASTATIN | 10MG | TABLET | Resolved | 2022-10-07 | 2022-11-25 | 171430 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2024-02-23 | 2024-04-05 | 220462 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-06-23 | 2023-07-21 | 196309 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-09-07 | 2024-03-01 | 203834 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-10-06 | 2023-12-01 | 206576 |
| APO-SIMVASTATIN | 10MG | TABLET | Resolved | 2023-11-10 | 2023-11-24 | 209939 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-02-09 | 2023-02-16 | 184080 |
| APO-SIMVASTATIN | 80MG | TABLET | Resolved | 2023-06-16 | 2023-06-29 | 195058 |
| APO-SITAGLIPTIN MALATE | 25MG | TABLET | Resolved | 2023-02-09 | 2023-04-06 | 184112 |
| APO-SITAGLIPTIN MALATE | 100MG | TABLET | Resolved | 2023-03-30 | 2023-04-14 | 188411 |
| APO-SITAGLIPTIN MALATE | 50MG | TABLET | Resolved | 2023-03-30 | 2023-05-19 | 188415 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |